MAPAX
Price
$31.33
Change
+$0.15 (+0.48%)
Updated
Jul 25 closing price
Net Assets
952.03M
VVIAX
Price
$70.44
Change
+$0.29 (+0.41%)
Updated
Jul 25 closing price
Net Assets
195.18B
Interact to see
Advertisement

MAPAX vs VVIAX

Header iconMAPAX vs VVIAX Comparison
Open Charts MAPAX vs VVIAXBanner chart's image
NYLI WMC Value
Price$31.33
Change+$0.15 (+0.48%)
VolumeN/A
Net Assets952.03M
Vanguard Value Index Adm
Price$70.44
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets195.18B
MAPAX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MAPAX vs. VVIAX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAPAX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 195B vs. MAPAX (952M). VVIAX pays higher dividends than MAPAX: VVIAX (2.18) vs MAPAX (1.39). MAPAX was incepted earlier than VVIAX: MAPAX (26 years) vs VVIAX (25 years). MAPAX (1.02) is less costly to investors than VVIAX (0.05). MAPAX is a more actively managed with annual turnover of: 38.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than MAPAX: VVIAX (3000) vs MAPAX (15000). VVIAX annual gain was more profitable for investors over the last year : 9.75 vs. MAPAX (6.20). VVIAX return over 5 years is better than : 74.87 vs. MAPAX (-14.64).
MAPAXVVIAXMAPAX / VVIAX
Total Expense Ratio1.020.052,040%
Annual Report Gross Expense Ratio1.020.052,040%
Fund Existence26 years25 years-
Gain YTD6.8926.714103%
Front Load6%N/A-
Min. Initial Investment150003000500%
Min. Initial Investment IRAN/AN/A-
Net Assets952M195B0%
Annual Yield % from dividends1.392.1864%
Returns for 1 year6.209.7564%
Returns for 3 years17.9434.3252%
Returns for 5 years-14.6474.87-20%
Returns for 10 years-25.13116.26-22%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVO4.260.21
+5.19%
Evotec SE
MAPS0.970.02
+2.12%
WM Technology
EG336.860.99
+0.29%
Everest Group Ltd
ARTL13.73-0.03
-0.22%
Artelo Biosciences Inc
BCAX11.75-0.18
-1.51%
Bicara Therapeutics Inc.